Supreme Court Keeps Mifepristone Mail Access Pending Appeal
High court stayed a 5th Circuit order blocking mail delivery of mifepristone, preserving pharmacy and mail access while litigation continues.
Mother JonesThe Supreme Court just hit pause on an abortion pill showdown
Daily SignalSupreme Court Lets Abortion Pill Mail Delivery Continue - The Daily Signal
TownhallU.S. Supreme Court Temporarily Restores Nationwide Mail Access to Abortion Pill
Scientific AmericanU.S. Supreme Court allows access to mifepristone by mail—for now
Overview
The Supreme Court on Thursday allowed women to continue obtaining mifepristone by mail or at pharmacies while an appeal proceeds.
The stay blocks a 5th Circuit order from May 1 that would have required in-person visits and halted mail delivery after two manufacturers sought emergency relief.
Justices Clarence Thomas and Samuel Alito dissented, with Thomas citing the Comstock Act and criticizing manufacturers Danco Laboratories and GenBioPro, and anti-abortion groups have pressed the FDA amid recent scrutiny.
Medication abortions accounted for nearly two-thirds of all abortions in the U.S. in 2023, according to available statistics.
The stay will remain in place until the justices decide whether to hear the manufacturers' case and the underlying litigation continues.
Analysis
Center-leaning sources frame the story as defending mifepristone access and public-health consensus, highlighting urgency and political motives. Editorial choices—lead wording ('ensured', 'politically radioactive'), prioritizing FDA and medical-group safety statements and drugmakers' disruption accounts—foreground harm to access, while conservative dissents are reported mainly as legal objections rather than scientific counterarguments.